# NAPROXEN SODIUM

NDC: 51013-137
Generic name: Naproxen Sodium
Labeler / Manufacturer: PuraCap Pharmaceutical LLC
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20180320

FDA application: ANDA208363

## Active ingredients

- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51013-137"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51013-137
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc865e81-164c-48e9-8fb9-6fc27d1c33cf